C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 121 filers reported holding C4 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,991 | +311.1% | 9,135 | +507.8% | 0.00% | – |
| Q2 2023 | $4,133 | -96.1% | 1,503 | -95.6% | 0.00% | – |
| Q1 2023 | $107,000 | +17974.3% | 33,863 | -66.3% | 0.00% | – |
| Q4 2022 | $592 | -99.7% | 100,482 | +281.1% | 0.00% | – |
| Q3 2022 | $231,000 | +23.5% | 26,365 | +6.4% | 0.00% | – |
| Q2 2022 | $187,000 | -88.9% | 24,782 | -64.3% | 0.00% | – |
| Q1 2022 | $1,684,000 | +82.1% | 69,420 | +141.7% | 0.00% | – |
| Q4 2021 | $925,000 | -62.2% | 28,722 | -47.6% | 0.00% | – |
| Q3 2021 | $2,450,000 | +292.0% | 54,829 | +231.6% | 0.00% | – |
| Q2 2021 | $625,000 | +171.7% | 16,536 | +166.2% | 0.00% | – |
| Q1 2021 | $230,000 | +44.7% | 6,211 | +29.7% | 0.00% | – |
| Q4 2020 | $159,000 | – | 4,787 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |